Перспективи та інновації науки,
Год журнала:
2024,
Номер
8(42)
Опубликована: Сен. 2, 2024
МІКРОБІОМ
ШКІРИ
ЛЮДИНИ:
ФОРМУВАННЯ,
РІЗНОМАНІТНІСТЬ
ТА
РОЛЬ
У
РОЗВИТКУ
ХВОРОБАнотація.Стаття
присвячена
мікробіому
людини,
віковим
змінам
і
топографічному
різноманіттю
мікробіоти
шкіри.Мікробіом
людини
включає
в
себе
різноманітні
асоціації
бактерій,
архей,
вірусів,
мікроскопічних
грибів
та
найпростіших,
які
сконцентровані
у
біотопах.Мікробіом
розглядають
як
унікальний
мікробний
орган
який
виконує
величезну
кількість
фізіологічних
функцій.Мікробіота
шкіри
забезпечує
колонізаційну
резистентність,
стимулює
лімфоїдну
тканину
Abstract
Fecal
microbiota
transplantation
(FMT)
has
emerged
as
a
promising
therapeutic
approach
for
dysbiosis‐related
diseases.
However,
the
clinical
practice
of
crude
fecal
transplants
presents
limitations
in
terms
acceptability
and
reproductivity.
Consequently,
two
alternative
solutions
to
FMT
are
developed:
transplanting
bacteria
communities
or
virome.
Advanced
methods
mainly
include
washed
spores
treatment.
Transplanting
virome
is
also
explored,
with
development
transplantation,
which
involves
filtering
from
feces.
These
approaches
provide
more
palatable
options
patients
healthcare
providers
while
minimizing
research
heterogeneity.
In
general,
evolution
next
generation
global
trends
components
focuses
on
The
intestinal
microbiota
has
major
influence
on
human
physiology
and
modulates
health
disease.
Complex
host–microbe
interactions
regulate
various
homeostatic
processes,
including
metabolism
immune
function,
while
disturbances
in
composition
(dysbiosis)
are
associated
with
a
plethora
of
diseases
believed
to
modulate
disease
initiation,
progression
therapy
response.
vast
complexity
the
its
metabolic
output
represents
great
challenge
unraveling
molecular
basis
specific
physiological
contexts.
To
increase
our
understanding
these
interactions,
functional
research
using
animal
models
reductionistic
setting
essential.
In
dynamic
landscape
gut
research,
use
germ‐free
gnotobiotic
mouse
technology,
which
causal
disease‐driving
mechanisms
can
be
dissected,
pivotal
investigative
tool
for
disease,
dissected.
A
better
health‐modulating
functions
opens
perspectives
improved
therapies
many
diseases.
this
review,
we
discuss
practical
considerations
design
execution
experiments,
around
rederivation
housing
conditions,
route
timing
microbial
administration,
dosing
protocols.
This
comprehensive
overview
aims
provide
researchers
valuable
insights
experimental
field
research.
Microorganisms,
Год журнала:
2025,
Номер
13(1), С. 54 - 54
Опубликована: Янв. 1, 2025
Recent
interest
in
the
diverse
ecosystem
of
bacteria,
fungi,
parasites,
and
viruses
that
make
up
skin
microbiome
has
led
to
several
studies
investigating
healthy
a
variety
dermatological
conditions.
An
imbalance
normal
flora
can
cause
some
diseases,
current
culture
techniques
are
often
unable
detect
microorganism
further
our
understanding
clinical–microbiological
correlates
disease
dysbiosis.
Atopic
dermatitis
rosacea
presentations
GPs
manage
may
have
an
infective
or
microbiological
component
be
challenging
treat.
We
aim
discuss
implications
including
impact
dysbiosis
on
conditions
such
as
these.
will
also
clinical
pearls
for
initial
future
directions
management
atopic
dermatitis,
rosacea,
hidradenitis
suppurativa.
Further
research
using
culture-independent
is
needed
involving
microbial
advance
knowledge
pathophysiology
guide
management.
Medicina,
Год журнала:
2024,
Номер
60(10), С. 1619 - 1619
Опубликована: Окт. 3, 2024
Psoriasis
is
a
common
chronic
inflammatory
skin
disease,
associated
with
significant
morbidity
and
considerable
negative
impact
on
the
patients'
quality
of
life.
The
complex
pathogenesis
psoriasis
still
incompletely
understood.
Genetic
predisposition,
environmental
factors
like
smoking,
alcohol
consumption,
psychological
stress,
consumption
certain
drugs,
mechanical
trauma,
as
well
specific
immune
dysfunctions,
contribute
to
onset
disease.
Mounting
evidence
indicate
that
dysbiosis
plays
role
in
development
exacerbation
through
loss
tolerance
commensal
flora,
an
altered
balance
between
Tregs
effector
cells,
excessive
Th1
Th17
polarization.
While
implications
are
only
starting
be
revealed,
progress
characterization
microbiome
changes
patients
has
opened
whole
new
avenue
research
focusing
modulation
adjuvant
treatment
for
part
long-term
plan
prevent
disease
flares.
may
also
represent
valuable
predictive
marker
response
aid
selection
optimal
personalized
treatment.
We
present
current
knowledge
results
studies
investigated
efficacy
different
strategies
management
psoriasis,
discuss
interaction
host
flora.
The
skin
microbiome
plays
a
pivotal
role
in
human
health
by
providing
protective
and
functional
benefits.
Furthermore,
its
inherent
stability
individual
specificity
present
novel
forensic
applications.
These
aspects
have
sparked
considerable
research
enthusiasm
among
scholars
across
various
fields.
However,
the
selection
of
specific
16S
rRNA
hypervariable
regions
for
studies
is
not
standardized
should
be
validated
through
extensive
tailored
to
different
objectives
targeted
bacterial
taxa.
Notably,
third-generation
sequencing
(TGS)
technology
leverages
full
discriminatory
power
gene
enables
more
detailed
accurate
microbial
community
analyses.
Here,
we
conducted
full-length
141
microbiota
samples
from
multiple
anatomical
sites
using
PacBio
platform.
Based
on
this
data,
generated
derived
sub-region
data
an
Clinical Cosmetic and Investigational Dermatology,
Год журнала:
2025,
Номер
Volume 18, С. 459 - 473
Опубликована: Фев. 28, 2025
The
influence
of
injectable
hyaluronic
gels
on
skin's
microbiota
is
unclear.
As
well,
skin
a
key
factor
modulating
final
effect
gels.
ex-vivo
study
was
aimed
at
alterations
following
acid
injection
into
the
dermis
in
non-sterile
surface
conditions.
Ex
vivo
human
explants
presence
or
absence
either
S.
epidermidis
aureus,
were
treated
with
control
excipient
(0.9%
sodium
chloride)
test
product
(Hyaluronic
S,
HA-S).
Bacterial
analysis
performed,
as
well
structural
integrity.
Histological
imaging
and
immunostaining
markers:
epidermal
(CD1a,
Toll-like
receptor
2
(TLR2),
Beta-defensin-3
(BD3),
CCN1)
dermal
(DC-SIGN,
Decorin)
then
performed.
E
P,
both
associated
bacterial
deposits,
induced
similar
noticeable
increase
growth
over
4
days,
but
no
aureus.
excipient,
showed
increased
time.
It
observed
significant
CD1a,
TLR2,
CCN1
DC-SIGN,
Decorin
Day
2.
product,
contrast
to
very
slight
improvement
viability
decrease
BD3,
DC-SIGN
Our
investigation
that
intradermal
injections,
HA-based
solution
trigger
short-term
growth.
We
indicate
strong
conditions
explant
when
barrier
damaged
by
puncture
highlights
differences
epidermal/dermal
response
depended
injected
composition.